and laser hair removal treatment. This case is relevant because it helps clinicians to remember that HS may be isolated to atypical locations, such as the anterior aspect of the neck and chin. It also supports another possible HS pathogenesis which consists of the occlusion of terminal hair follicles rather than being essentially a disorder of the apocrine glands.
Case Report
A 40-year-old man presented for a second opinion with a 3-year history of chronic painful subcutaneous nodules, deep sinus tracts, and abscesses involving the jawline and the anterior aspect of the neck. He had been previously managed as persistent adult acne. Initially, the lesions appeared to be folliculitis with trapped hairs, which later transformed into subcutaneous nodules that drained intermittently and healed with hypertrophic scars, simulating severe cystic acne. The patient had no personal or family history of acne vulgaris, HS, diabetes, or gastrointestinal illness. He had previously been treated with multiple courses of topical and oral antibiotics, which resulted in partial and temporary improvement.
On examination, there were numerous rope-like hypertrophic scars within raised inflammatory plaques, deep-seated nodules, sinuses, and fistulae with purulent and bloody discharge on the jawline and the anterior neck ( Fig. 1 a, b ). There were no other skin lesions elsewhere. Punch biopsies for hematoxylin-eosin, fungal polymerase chain reaction, as well as fungal and bacterial cultures were performed. The hematoxylin-eosin biopsy showed an epidermis which was covered by a parakeratotic stratum corneum. There was extensive underlying fibrosis, and only isolated follicles remained. There were increased vessels present together with lymphocytic inflammation and plasma cells as well as an area of ulceration covered by fibrin, locules of serum, and neutrophilic debris ( Fig. 2 a, b ). All the tests were negative for any causative microorganisms. Isotretinoin 10 mg/daily for 10 months was tried, with no improvement. Given the clinical features, the lack of a primary infectious disease, and the absent response to acne treatment, the diagnosis of HS in an atypical location was made. He was found to be insulin resistant as well. The insulin resistance was established by measuring serum insulin values before and after a 75 g oral glucose tolerance test. The insulin levels were 13 mU/L (normal <10 mU/L), 130 mU/L (normal <60 mU/L), and 44 mU/L (normal <60 mU/L) when fasting and 1 and 2 h after glucose challenge, respectively.
Considering the severity of the disease (Sartorius score 70 and Hurley stage 2) and the lack of response to other conventional treatments, biologic therapy with adalimumab 40 mg/weekly was added initially to isotretinoin. Three months later, the patient improved significantly (Sartorius score 59) and isotretinoin was ceased. Subsequently, monthly laser treatment was added as an adjuvant therapy to avoid trapped hairs (long-pulsed Nd:YAG laser, 1,064 nm wavelength). After 1 year of ongoing treatment with adalimumab and laser treatment, the patient continued to improve, with a Sartorius score of 14 ( Fig. 1 c, d, 3 ) . Atypical areas including the ears, face, posterior neck, chest, and back have been described in patients with HS in case reports and case series, especially in men [1] [2] [3] . These locations are infrequent, and most of the cases reported showed lesions of HS in unusual locations associated with other typical areas affected, which facilitates the diagnosis [2, 3] . In this case, the diagnosis was not straightforward considering that the only parts of the body compromised were the anterior neck and jawline. The most important differential diagnoses considered were an in- 
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Color version available online fectious disease or acne conglobata. All the tests performed helped to rule out an infectious cause. Some clinical features help to distinguish between HS and acne conglobata. Closed comedones are present in the latter and absent in the former, while the rope-like bridged scars are typical of HS and are different from the common hypertrophic or keloidal acne scars [3] . Thus, the clinical appearance of the lesions, the lack of response to isotretinoin, and a satisfactory response to adalimumab, one of the biologics with the strongest evidence to treat HS [4] , allowed us to conclude that this patient has a localized form of HS involving an atypical location, instead of a severe type of acne. Moreover, the involvement of atypical locations such as the anterior neck and jawline (areas with an abundant number of terminal hair follicles) in this case supports another possible pathogenic theory of HS, which consists of the occlusion of terminal hair follicles rather than to be essentially a disorder of the apocrine glands [5] [6] [7] . The present case is relevant given that it helps clinicians to remember that HS may be isolated in atypical locations, such as the anterior aspect of the neck and chin. Early recognition of this atypical presentation of HS and treatment with a biological agent if the patient is not responding to standard therapy is important to prevent scarring.
